A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
Active, not recruiting · NCT03634540 · Registry updated 2024-12-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 2 | 2024-12-20 | NCT03634540 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 4 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) | Los Angeles | United States | 1 |
| Dana Farber Cancer Center ( Site 0006) | Boston | United States | 1 |
| Karmanos Cancer Institute ( Site 0033) | Detroit | United States | 1 |
| Seattle Cancer Care Alliance/Univ of Washington Medical Center ( Site 0035) | Seattle | United States | 1 |
| Swedish Cancer Institute ( Site 0018) | Seattle | United States | 1 |
| Sylvester Comprehensive Cancer Center ( Site 0023) | Miami | United States | 1 |
| Tennessee Oncology, PLLC ( Site 0001) | Nashville | United States | 1 |
| Tennessee Oncology, PLLC ( Site 0024) | Chattanooga | United States | 1 |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 0010) | Dallas | United States | 1 |
| USC Norris Comprehensive Cancer Center ( Site 0060) | Los Angeles | United States | 1 |